arXivDaily arXiv每日学术速递 周一至周五更新
arXiv周末暂无论文更新,休息一下吧,周末愉快~~
arXiv 2501.13376eess.IVcs.CV

基础模型在骨科MRI中的临床效用:生物标志物准确性与预测结果

Clinical utility of foundation models in musculoskeletal MRI for biomarker fidelity and predictive outcomes

Center for Intelligent Imaging, Department of Radiology and Biomedical Imaging, University of California, San Francisco(加利福尼亚大学旧金山分校放射与生物医学影像系智能成像中心);Department of Bioengineering, University of California, Berkeley(加利福尼亚大学伯克利分校生物工程系);Department of Bioengineering and Therapeutic Sciences, University of California, San Francisco(加利福尼亚大学旧金山分校生物工程与治疗科学系);Department of Medical Sciences and Technology, Indian Institute of Technology, Madras(印度理工学院马德拉斯分校医学科学与技术系);Bay Area Institute of Computation, Altos Labs(Altos Labs湾区计算研究所)

Gabrielle Hoyer, Michelle W Tong, Rupsa Bhattacharjee, Valentina Pedoia, Sharmila Majumdar

AI总结:

本文提出了一种模块化系统,将常规MRI转化为标准化定量生物标志物,用于临床决策支持。通过微调基础分割模型,实现了自动检测和提示,提高了生物标志物的临床可靠性,并展示了其在膝关节分层和预测膝关节置换及骨关节炎中的应用。

摘要:

骨科影像的精准医学需要可扩展的测量基础设施。我们开发了一种模块化系统,将常规MRI转化为标准化定量生物标志物,适用于临床决策支持。通过微调异构骨科数据集的提示基础分割器(SAM、SAM2、MedSAM)并结合自动检测,实现了全自动提示。微调后的分割结果在软骨、骨和软组织生物标志物上与专家标注高度一致。使用相同测量,我们展示了两种应用:(i)三阶段膝关节分层流程,减少验证工作量同时保持灵敏度;(ii)48个月地标模型可预测膝关节置换和骨关节炎,具有良好的校准和净效益。我们的模型无关、开源架构支持独立验证和开发。本工作验证了从自动测量到临床决策的路径:可靠的生物标志物驱动今日的工作量优化和明日的患者风险分层,该框架展示了基础模型如何在精准医学系统中实现操作化。

英文摘要:

Precision medicine in musculoskeletal imaging requires scalable measurement infrastructure. We developed a modular system that converts routine MRI into standardized quantitative biomarkers suitable for clinical decision support. Promptable foundation segmenters (SAM, SAM2, MedSAM) were fine-tuned across heterogeneous musculoskeletal datasets and coupled to automated detection for fully automatic prompting. Fine-tuned segmentations yielded clinically reliable measurements with high concordance to expert annotations across cartilage, bone, and soft tissue biomarkers. Using the same measurements, we demonstrate two applications: (i) a three-stage knee triage cascade that reduces verification workload while maintaining sensitivity, and (ii) 48-month landmark models that forecast knee replacement and incident osteoarthritis with favorable calibration and net benefit across clinically relevant thresholds. Our model-agnostic, open-source architecture enables independent validation and development. This work validates a pathway from automated measurement to clinical decision: reliable biomarkers drive both workload optimization today and patient risk stratification tomorrow, and the developed framework shows how foundation models can be operationalized within precision medicine systems.

机构、总结、中文摘要均由AI分析而来,可能存在错误,请以论文正文为准。

↑